Atomi Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$800K Sell
12,745
-2,678
-17% -$214K 0.02% 514
2025
Q4
$1.47M Buy
15,423
+1,978
+15% +$194K 0.04% 304
2025
Q3
$1.31M Buy
13,445
+2,436
+22% +$252K 0.04% 294
2025
Q2
$1.18M Buy
11,009
+514
+5% +$52K 0.04% 292
2025
Q1
$1.06M Buy
10,495
+864
+9% +$87K 0.05% 300
2024
Q4
$860K Buy
9,631
+1,365
+17% +$120K 0.04% 305
2024
Q3
$693K Buy
8,266
+997
+14% +$78.6K 0.04% 342
2024
Q2
$560K Buy
7,269
+1,239
+21% +$90.7K 0.04% 356
2024
Q1
$413K Buy
6,030
+1,163
+24% +$74.8K 0.04% 408
2023
Q4
$281K Buy
+4,867
New +$260K 0.04% 434

Other funds holding BSX

Atomi Financial Group's BSX Position: Q1 2026 in Review

Atomi Financial Group reduced its Boston Scientific (BSX) stake by 17% in Q1 2026, selling an estimated $214K and leaving 12,745 shares worth $800K. The position accounts for 0.02% of the portfolio, ranked #514.

Atomi Financial Group first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.47M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Atomi Financial Group held 12,745 shares of Boston Scientific worth $800K as of Q1 2026.
  • Atomi Financial Group sold 2,678 Boston Scientific shares in Q1 2026, an estimated $214K.
  • Boston Scientific made up 0.02% of Atomi Financial Group's portfolio in Q1 2026, its #514 holding.
  • Atomi Financial Group first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
  • Atomi Financial Group's Boston Scientific position peaked at $1.47M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.